chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Eczema, Pruritus, Skin irritation
Clinical narrative: Vaccine #1: 4/13/21, developed systemic itching -> resolved without treatment   Vaccine #2: 5/4/21, developed systemic itching w/ skin irritation 5 days later --> Benadryl used w/ relief 5/14/21: presented to PCP office for continued systemic itching and treated with prednisone po 40mg QD x5 days Symptoms resolved with treatment until approx. 6/2/2021 when systemic itching returned.  6/13/21: itching returned w/ areas of erythema on forearm and itching of low back. 6/15/21: presented to PCP office for continued symptoms - treated with prednisone po 40mg QD x5 days.   approximately 1/2 week after the 1st injection Major itching began, Lasted about Two weeks, Took over counter Medication (Benadryl etc.) After Second injection the Same itching return Very Severely. On both cases Prednisone Controled the itch. To date 6/28/21 Minor itchy has Continued at a Moderate to lower Level. Itch Cream and other allergy medication by Mouth. All ocassions itch Location  Left arm and hand - Where Surgery + arm staff infection occured in the past. Left Leg  Back of Neck upper back - Where Lamanectomy Surgery occured C1-C7 in the past 1998 Navel area 1 inch wide around Navel where Shingles occured Lower back area where Back injection occured in the past  Right Leg  Right Real bad where Ezeama is Current and in the past Private area Testicles   Please find an account of My Medical reaction to the Pfizer. My Signature below authorized you to obtain medical Records Pertaining to My Pfizer vaccines   At our last appointment, your wife expressed concern that your skin condition be reported to Pfizer since this started after your COVID vaccine.  I have completed the essential portions of the form.  You can add additional information as is appropriate.  See the third page for how to submit the form if you are still interested in doing so.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: administered past the current refrigeration beyond use date as listed
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling, Ultrasound scan
Clinical narrative: I have had lymphedema in my left leg for over 45 years and 3 days after the first COVID 19 shot in the right arm, I got swelling in my right leg now and it hasn't gone away since.
Age: 87.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anal incontinence, Asthenia, Confusional state
Clinical narrative: COMPLETELY UNABLE TO RISE FROM BED, LIFT LIMBS OR MOVE HANDS OR FEET, TOTAL LOSS OF STRENGTH TO MOVE. SEE CONTINUATION PAGE.
Age: 87.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arrhythmia, Asthenia, Atrial fibrillation, Atrial flutter, Mobility decreased
Clinical narrative: COMPLETELY UNABLE TO RISE FROM BED, LIFT LIMBS OR MOVE HANDS OR FEET, TOTAL LOSS OF STRENGTH TO MOVE. SEE CONTINUATION PAGE.
Age: 87.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Supraventricular tachycardia, Troponin increased
Clinical narrative: COMPLETELY UNABLE TO RISE FROM BED, LIFT LIMBS OR MOVE HANDS OR FEET, TOTAL LOSS OF STRENGTH TO MOVE. SEE CONTINUATION PAGE.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test normal, Chest X-ray normal, Chest discomfort, Hypersensitivity, Palpitations
Clinical narrative: Within a few minutes of the first shot, I felt my heart racing.  I then felt lightheaded and had chest pain with  some PVCs on the monitor.I was sent to the ER. No medication given.  I was monitor for roughly 2 hrs and sent home.  I did not receive the second shot.  I, then presented to the ER on 5/31/21 with chest pain and tachycardia. I was diagnosed with pericarditis.  The assumed pericarditis diagnosis was unknown but pressured to be viral pericarditis.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Troponin T normal
Clinical narrative: Within a few minutes of the first shot, I felt my heart racing.  I then felt lightheaded and had chest pain with  some PVCs on the monitor.I was sent to the ER. No medication given.  I was monitor for roughly 2 hrs and sent home.  I did not receive the second shot.  I, then presented to the ER on 5/31/21 with chest pain and tachycardia. I was diagnosed with pericarditis.  The assumed pericarditis diagnosis was unknown but pressured to be viral pericarditis.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Cardiac stress test, Chest X-ray, Chest pain, Dizziness
Clinical narrative: Within a few minutes of the first shot, I felt my heart racing.  I then felt lightheaded and had chest pain with  some PVCs on the monitor.I was sent to the ER. No medication given.  I was monitor for roughly 2 hrs and sent home.  I did not receive the second shot.  I, then presented to the ER on 5/31/21 with chest pain and tachycardia. I was diagnosed with pericarditis.  The assumed pericarditis diagnosis was unknown but pressured to be viral pericarditis.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Echocardiogram, Electrocardiogram, Full blood count, Incomplete course of vaccination, Metabolic function test
Clinical narrative: Within a few minutes of the first shot, I felt my heart racing.  I then felt lightheaded and had chest pain with  some PVCs on the monitor.I was sent to the ER. No medication given.  I was monitor for roughly 2 hrs and sent home.  I did not receive the second shot.  I, then presented to the ER on 5/31/21 with chest pain and tachycardia. I was diagnosed with pericarditis.  The assumed pericarditis diagnosis was unknown but pressured to be viral pericarditis.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations, Tachycardia, Troponin, Ventricular extrasystoles, Viral pericarditis
Clinical narrative: Within a few minutes of the first shot, I felt my heart racing.  I then felt lightheaded and had chest pain with  some PVCs on the monitor.I was sent to the ER. No medication given.  I was monitor for roughly 2 hrs and sent home.  I did not receive the second shot.  I, then presented to the ER on 5/31/21 with chest pain and tachycardia. I was diagnosed with pericarditis.  The assumed pericarditis diagnosis was unknown but pressured to be viral pericarditis.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cough, Feeling hot, Heart rate increased, Oral pruritus, Paraesthesia oral
Clinical narrative: itchy mouth; burning/extreme heat in abdomen.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EM9810), via an unspecified route of administration in the right arm as single dose (at the age of 36-years-old) on 11Feb2021 at 08:15.  Medical history included asthma. The patient had seasonal allergies, pet dander allergy, dust mites and mold allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient received other medications (unspecified) within 2 weeks of vaccination. Patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN620), via an unspecified route of administration in the right arm on 04Mar2021 (at the age of 36-years-old); as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, patient had not been tested for COVID-19. On 11Feb2021 at around 08:30, 8 minutes after the first shot, the patient experienced rush of heat concentrating in lower abdomen followed by a brief bout of an itchy mouth. The patient was observed for an hour and BP, heart rate and oxygen levels were monitored. BP, heart rate and oxygen levels readings were fine with no further issue. After leaving the vaccination site, the patient had several feelings of burning/extreme heat in abdomen. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events burning in abdomen and itching mouth were resolved on an unknown date.   No follow-up attempts possible. No further information expected.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rhinorrhoea
Clinical narrative: itchy mouth; burning/extreme heat in abdomen.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EM9810), via an unspecified route of administration in the right arm as single dose (at the age of 36-years-old) on 11Feb2021 at 08:15.  Medical history included asthma. The patient had seasonal allergies, pet dander allergy, dust mites and mold allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient received other medications (unspecified) within 2 weeks of vaccination. Patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN620), via an unspecified route of administration in the right arm on 04Mar2021 (at the age of 36-years-old); as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, patient had not been tested for COVID-19. On 11Feb2021 at around 08:30, 8 minutes after the first shot, the patient experienced rush of heat concentrating in lower abdomen followed by a brief bout of an itchy mouth. The patient was observed for an hour and BP, heart rate and oxygen levels were monitored. BP, heart rate and oxygen levels readings were fine with no further issue. After leaving the vaccination site, the patient had several feelings of burning/extreme heat in abdomen. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events burning in abdomen and itching mouth were resolved on an unknown date.   No follow-up attempts possible. No further information expected.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Blood pressure measurement, Heart rate, Oral pruritus, Oxygen saturation
Clinical narrative: itchy mouth; burning/extreme heat in abdomen.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EM9810), via an unspecified route of administration in the right arm as single dose (at the age of 36-years-old) on 11Feb2021 at 08:15.  Medical history included asthma. The patient had seasonal allergies, pet dander allergy, dust mites and mold allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient received other medications (unspecified) within 2 weeks of vaccination. Patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN620), via an unspecified route of administration in the right arm on 04Mar2021 (at the age of 36-years-old); as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, patient had not been tested for COVID-19. On 11Feb2021 at around 08:30, 8 minutes after the first shot, the patient experienced rush of heat concentrating in lower abdomen followed by a brief bout of an itchy mouth. The patient was observed for an hour and BP, heart rate and oxygen levels were monitored. BP, heart rate and oxygen levels readings were fine with no further issue. After leaving the vaccination site, the patient had several feelings of burning/extreme heat in abdomen. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events burning in abdomen and itching mouth were resolved on an unknown date.   No follow-up attempts possible. No further information expected.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Parosmia
Clinical narrative: A constant strange smell. It kind of smells stale with hint of ashtray/fireplace; This is a spontaneous report from a contactable consumer or other Non-health care professional. A 57-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6201), via intramuscularly in left arm on 15Feb2021 12:15 as dose 1 single for covid-19 immunization. Medical history included sinusitis and hypertension from an unknown date if ongoing. The patient previously took lisinopril and gabapentin and experienced drug hypersensitivity. Concomitant medications included beclometasone dipropionate (QNASL), amlodipine besilate, atorvastatin calcium (CADUET), modafinil and levocetirizine dihydrochloride taken for an unspecified indication, start and stop date were not reported. it was reported that patient doesnt had covid prior vaccination and was not tested to covid post vaccination. patient had not received other vaccine in four weeks. A constant strange smell. It kind of smells stale with hint of ashtray/fireplace. It occurs anywhere I go. I can still the normal things that I usually have before this began. It's really difficult to explain. I still smell and still taste with no problem. It is just very annoying. The patient experienced a constant strange smell. it kind of smells stale with hint of ashtray/fireplace on 21Feb2021 18:00. It occurs anywhere he go and can still do the normal things that he usually had before this began. It was reported that it was really difficult to explain and stated that patient can still smell and still taste with no problem. It was just very annoying. Patient had not received any treatment for the event. Outcome of event was reported as not recovered. Follow-up attempts completed. No further information expected.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Hypoaesthesia, Lymphadenopathy, Vomiting
Clinical narrative: Vomiting for two days after shot and ondansetron prescribed; swollen glands on left side neck and clavical area; numbness in hands and fingers; raised blood pressure; 103F fever on day after shot; This is a spontaneous report from a contactable consumer (patient) reported for herself that, A 56-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6205), dose 2 via an unspecified route of administration, administered in Arm Left on 01Mar2021 03:45 (at the age of 56-years-old) as dose 2, single for covid-19 immunization. Medical history included known allergies to Latex. There were no concomitant medications. Patient did not receive other vaccine in four weeks of vaccination. Patient did not receive Other medications in two weeks of vaccinations. Patient was not diagnosed with COVID-19, prior vaccination. Patient has not been tested for COVID-19, post vaccination. Patient took first dose of bnt162b2 (Batch/Lot Number: EM9809), in Arm left, on 08Feb2021 03:45 for covid-19 immunization. On 02Mar2021, the patient experienced vomiting for two days after shot and ondansetron prescribed, swollen glands on left side neck and clavical area, numbness in hands and fingers, raised blood pressure and 103f fever on day after shot. The events resulted to physician office visit. (serious: no, as reported). The patient underwent lab tests and procedures which included blood pressure measurement: raised and body temperature: 103 fahrenheit on 02Mar2021. Treatment was received for the adverse events as ondansetron. Outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Body temperature, Hypoaesthesia, Lymphadenopathy
Clinical narrative: Vomiting for two days after shot and ondansetron prescribed; swollen glands on left side neck and clavical area; numbness in hands and fingers; raised blood pressure; 103F fever on day after shot; This is a spontaneous report from a contactable consumer (patient) reported for herself that, A 56-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6205), dose 2 via an unspecified route of administration, administered in Arm Left on 01Mar2021 03:45 (at the age of 56-years-old) as dose 2, single for covid-19 immunization. Medical history included known allergies to Latex. There were no concomitant medications. Patient did not receive other vaccine in four weeks of vaccination. Patient did not receive Other medications in two weeks of vaccinations. Patient was not diagnosed with COVID-19, prior vaccination. Patient has not been tested for COVID-19, post vaccination. Patient took first dose of bnt162b2 (Batch/Lot Number: EM9809), in Arm left, on 08Feb2021 03:45 for covid-19 immunization. On 02Mar2021, the patient experienced vomiting for two days after shot and ondansetron prescribed, swollen glands on left side neck and clavical area, numbness in hands and fingers, raised blood pressure and 103f fever on day after shot. The events resulted to physician office visit. (serious: no, as reported). The patient underwent lab tests and procedures which included blood pressure measurement: raised and body temperature: 103 fahrenheit on 02Mar2021. Treatment was received for the adverse events as ondansetron. Outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Vomiting for two days after shot and ondansetron prescribed; swollen glands on left side neck and clavical area; numbness in hands and fingers; raised blood pressure; 103F fever on day after shot; This is a spontaneous report from a contactable consumer (patient) reported for herself that, A 56-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6205), dose 2 via an unspecified route of administration, administered in Arm Left on 01Mar2021 03:45 (at the age of 56-years-old) as dose 2, single for covid-19 immunization. Medical history included known allergies to Latex. There were no concomitant medications. Patient did not receive other vaccine in four weeks of vaccination. Patient did not receive Other medications in two weeks of vaccinations. Patient was not diagnosed with COVID-19, prior vaccination. Patient has not been tested for COVID-19, post vaccination. Patient took first dose of bnt162b2 (Batch/Lot Number: EM9809), in Arm left, on 08Feb2021 03:45 for covid-19 immunization. On 02Mar2021, the patient experienced vomiting for two days after shot and ondansetron prescribed, swollen glands on left side neck and clavical area, numbness in hands and fingers, raised blood pressure and 103f fever on day after shot. The events resulted to physician office visit. (serious: no, as reported). The patient underwent lab tests and procedures which included blood pressure measurement: raised and body temperature: 103 fahrenheit on 02Mar2021. Treatment was received for the adverse events as ondansetron. Outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Urticaria
Clinical narrative: Tiny tip blisters; Rash on left arm and back.; Small welts; This is a spontaneous report from a contactable consumer, the patient. A 53-years-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) via unspecified route of administration in left arm on 16Mar2021 at 11:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. The patient medical history included asthma and thyroid. The patient had environmental allergies. The patients concomitant medications included levothyroxine (MANUFRACTURER UNKNOWN), hydrochlorothiazide (MANUFRACTURER UNKNOWN), A (unspecified), C (unspecified), calcium and iron. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to vaccination. On 18Mar2021 at 07:00, the patient experienced rash on left arm and back. It went from a rash to small welts to tiny tip blisters. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment with BENADRYL but did not work, then prednisone was prescribed for the reported events. The clinical outcome of the events rash on left arm and back, small welts and tiny tip blisters was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blister, Rash, Urticaria
Clinical narrative: Tiny tip blisters; Rash on left arm and back.; Small welts; This is a spontaneous report from a contactable consumer, the patient. A 53-years-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) via unspecified route of administration in left arm on 16Mar2021 at 11:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. The patient medical history included asthma and thyroid. The patient had environmental allergies. The patients concomitant medications included levothyroxine (MANUFRACTURER UNKNOWN), hydrochlorothiazide (MANUFRACTURER UNKNOWN), A (unspecified), C (unspecified), calcium and iron. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to vaccination. On 18Mar2021 at 07:00, the patient experienced rash on left arm and back. It went from a rash to small welts to tiny tip blisters. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment with BENADRYL but did not work, then prednisone was prescribed for the reported events. The clinical outcome of the events rash on left arm and back, small welts and tiny tip blisters was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Aspartate aminotransferase increased, Blood bilirubin increased, Blood urea decreased, Chills, Cough
Clinical narrative: Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; headaches; fever; fatigue; night sweats; chills; loss of appetite; cough; This is a spontaneous report from a contactable consumer. This consumer reported for herself that a 23-year-old non-pregnant female patient received first dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, Batch/Lot Number: EN6206), (at the age of 23-year-old) via an unspecified route of administration in right arm on 11Mar2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. She had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. On 14Mar2021, for the past 6 days now, she had been experiencing the following symptoms: headaches, fever, fatigue, night sweats, chills, loss of appetite, and a cough. Got blood tests done on the 16Mar2021, abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin and abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN. The adverse event resulted in emergency room. There was no covid prior vaccination. On 16Mar2021, she had covid test post vaccination by nasal swab which resulted in negative. No treatment for event was provided. The outcome of the events was not recovered.  Information about lot/batch number was obtained. Additional information has been requested.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Decreased appetite, Eosinophil count decreased, Fatigue, Headache, Immature granulocyte count increased
Clinical narrative: Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; headaches; fever; fatigue; night sweats; chills; loss of appetite; cough; This is a spontaneous report from a contactable consumer. This consumer reported for herself that a 23-year-old non-pregnant female patient received first dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, Batch/Lot Number: EN6206), (at the age of 23-year-old) via an unspecified route of administration in right arm on 11Mar2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. She had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. On 14Mar2021, for the past 6 days now, she had been experiencing the following symptoms: headaches, fever, fatigue, night sweats, chills, loss of appetite, and a cough. Got blood tests done on the 16Mar2021, abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin and abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN. The adverse event resulted in emergency room. There was no covid prior vaccination. On 16Mar2021, she had covid test post vaccination by nasal swab which resulted in negative. No treatment for event was provided. The outcome of the events was not recovered.  Information about lot/batch number was obtained. Additional information has been requested.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphocyte count decreased, Monocyte count decreased, Neutrophil count increased, Night sweats, Pyrexia
Clinical narrative: Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; headaches; fever; fatigue; night sweats; chills; loss of appetite; cough; This is a spontaneous report from a contactable consumer. This consumer reported for herself that a 23-year-old non-pregnant female patient received first dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, Batch/Lot Number: EN6206), (at the age of 23-year-old) via an unspecified route of administration in right arm on 11Mar2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. She had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. On 14Mar2021, for the past 6 days now, she had been experiencing the following symptoms: headaches, fever, fatigue, night sweats, chills, loss of appetite, and a cough. Got blood tests done on the 16Mar2021, abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin and abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN. The adverse event resulted in emergency room. There was no covid prior vaccination. On 16Mar2021, she had covid test post vaccination by nasal swab which resulted in negative. No treatment for event was provided. The outcome of the events was not recovered.  Information about lot/batch number was obtained. Additional information has been requested.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; headaches; fever; fatigue; night sweats; chills; loss of appetite; cough; This is a spontaneous report from a contactable consumer. This consumer reported for herself that a 23-year-old non-pregnant female patient received first dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, Batch/Lot Number: EN6206), (at the age of 23-year-old) via an unspecified route of administration in right arm on 11Mar2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. She had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. On 14Mar2021, for the past 6 days now, she had been experiencing the following symptoms: headaches, fever, fatigue, night sweats, chills, loss of appetite, and a cough. Got blood tests done on the 16Mar2021, abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin and abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN. The adverse event resulted in emergency room. There was no covid prior vaccination. On 16Mar2021, she had covid test post vaccination by nasal swab which resulted in negative. No treatment for event was provided. The outcome of the events was not recovered.  Information about lot/batch number was obtained. Additional information has been requested.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Aspartate aminotransferase increased, Blood bilirubin, Blood bilirubin increased, Blood urea, Blood urea decreased
Clinical narrative: Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; headaches; fever; fatigue; night sweats; chills; loss of appetite; cough; This is a spontaneous report from a contactable consumer. This consumer reported for herself that a 23-year-old non-pregnant female patient received first dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, Batch/Lot Number: EN6206), (at the age of 23-year-old) via an unspecified route of administration in right arm on 11Mar2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. She had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. On 14Mar2021, for the past 6 days now, she had been experiencing the following symptoms: headaches, fever, fatigue, night sweats, chills, loss of appetite, and a cough. Got blood tests done on the 16Mar2021, abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin and abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN. The adverse event resulted in emergency room. There was no covid prior vaccination. On 16Mar2021, she had covid test post vaccination by nasal swab which resulted in negative. No treatment for event was provided. The outcome of the events was not recovered.  Information about lot/batch number was obtained. Additional information has been requested.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Cough, Decreased appetite, Eosinophil count, Eosinophil percentage decreased
Clinical narrative: Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; headaches; fever; fatigue; night sweats; chills; loss of appetite; cough; This is a spontaneous report from a contactable consumer. This consumer reported for herself that a 23-year-old non-pregnant female patient received first dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, Batch/Lot Number: EN6206), (at the age of 23-year-old) via an unspecified route of administration in right arm on 11Mar2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. She had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. On 14Mar2021, for the past 6 days now, she had been experiencing the following symptoms: headaches, fever, fatigue, night sweats, chills, loss of appetite, and a cough. Got blood tests done on the 16Mar2021, abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin and abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN. The adverse event resulted in emergency room. There was no covid prior vaccination. On 16Mar2021, she had covid test post vaccination by nasal swab which resulted in negative. No treatment for event was provided. The outcome of the events was not recovered.  Information about lot/batch number was obtained. Additional information has been requested.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Immature granulocyte count, Immature granulocyte count increased, Lymphocyte count
Clinical narrative: Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; headaches; fever; fatigue; night sweats; chills; loss of appetite; cough; This is a spontaneous report from a contactable consumer. This consumer reported for herself that a 23-year-old non-pregnant female patient received first dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, Batch/Lot Number: EN6206), (at the age of 23-year-old) via an unspecified route of administration in right arm on 11Mar2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. She had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. On 14Mar2021, for the past 6 days now, she had been experiencing the following symptoms: headaches, fever, fatigue, night sweats, chills, loss of appetite, and a cough. Got blood tests done on the 16Mar2021, abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin and abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN. The adverse event resulted in emergency room. There was no covid prior vaccination. On 16Mar2021, she had covid test post vaccination by nasal swab which resulted in negative. No treatment for event was provided. The outcome of the events was not recovered.  Information about lot/batch number was obtained. Additional information has been requested.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphocyte count decreased, Monocyte percentage, Monocyte percentage decreased, Neutrophil count, Neutrophil count increased
Clinical narrative: Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; headaches; fever; fatigue; night sweats; chills; loss of appetite; cough; This is a spontaneous report from a contactable consumer. This consumer reported for herself that a 23-year-old non-pregnant female patient received first dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, Batch/Lot Number: EN6206), (at the age of 23-year-old) via an unspecified route of administration in right arm on 11Mar2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. She had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. On 14Mar2021, for the past 6 days now, she had been experiencing the following symptoms: headaches, fever, fatigue, night sweats, chills, loss of appetite, and a cough. Got blood tests done on the 16Mar2021, abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin and abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN. The adverse event resulted in emergency room. There was no covid prior vaccination. On 16Mar2021, she had covid test post vaccination by nasal swab which resulted in negative. No treatment for event was provided. The outcome of the events was not recovered.  Information about lot/batch number was obtained. Additional information has been requested.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Night sweats, Pyrexia, SARS-CoV-2 test negative, White blood cell count, White blood cell count increased
Clinical narrative: Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; Abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN.; headaches; fever; fatigue; night sweats; chills; loss of appetite; cough; This is a spontaneous report from a contactable consumer. This consumer reported for herself that a 23-year-old non-pregnant female patient received first dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, Batch/Lot Number: EN6206), (at the age of 23-year-old) via an unspecified route of administration in right arm on 11Mar2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. She had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. On 14Mar2021, for the past 6 days now, she had been experiencing the following symptoms: headaches, fever, fatigue, night sweats, chills, loss of appetite, and a cough. Got blood tests done on the 16Mar2021, abnormal/high values were in the following: WBC, Neutro, immature granulocyte, neutro absolute, immature granulocyte absolute, AST, bilirubin and abormal/low values were in the following: lymph, monocyte %, eosinophil %, BUN. The adverse event resulted in emergency room. There was no covid prior vaccination. On 16Mar2021, she had covid test post vaccination by nasal swab which resulted in negative. No treatment for event was provided. The outcome of the events was not recovered.  Information about lot/batch number was obtained. Additional information has been requested.